APOBEC3B and ductal breast carcinoma in situ: In this study we investigated APOBEC3B mRNA expression levels in synchronous DCIS and IBC and correlated the expression with PIK3CA mutation status in order to increase our understanding regarding the expression levels of this enzyme during progression from the in situ to the invasive stage.